Actively Recruiting
Monitoring Adverse Pregnancy and Newborn Outcomes in HIV-Positive and HIV-Negative Women A Multiregional Pharmacovigilance Study by IeDEA and Indiana University
Led by Indiana University · Updated on 2026-08-24
2800
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are developing a pharmacovigilance PV program to monitor adverse pregnancy and infant outcomes, including congenital abnormalities, among HIV-positive and HIV-negative women and their infants at clinical sites linked to the International Epidemiology Databases to Evaluate consortium IeDEA. The study uses a mixed prospective and cross-sectional cohort design to understand possible associations between antiretroviral treatment ART and pregnancy and infant outcomes. The study has three parts Cohort 1 involves prospective recruitment of pregnant women attending antenatal clinics ANC with follow-up including medical record collection and field contact if delivery occurs outside the site. Cohort 2 collects retrospective data from medical records of all deliveries at the site. Cohort 3 focuses on infants with suspected congenital abnormalities CAs, using photos and videos reviewed by experts, with follow-up calls at 1, 6, and 12 months post-delivery to monitor infant health and care engagement. Participants will have pregnancy and infant outcomes assessed at delivery and at 1, 6, and 12 months after birth. Data collection includes medical records, physical exams for congenital abnormalities, and photographic documentation. The study establishes a multiregional PV infrastructure with a Data Coordinating Center at Indiana University to manage and analyze data from Kenya and South Africa. The total study period extends through May 2031, with ongoing participant monitoring and data analysis.
CONDITIONS
Brief Title
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here